Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma.

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma. Clin Genitourin Cancer. 2017 04; 15(2):207-212.

View in: PubMed

subject areas

Administration, Oral
Aged
Aged, 80 and over
Angiogenesis Inhibitors
Contrast Media
Disease Progression
Female
Humans
Indazoles
Kidney Neoplasms
Magnetic Resonance Imaging
Male
Middle Aged
Neoplasm Metastasis
Pyrimidines
Sulfonamides
Treatment Outcome

authors with profiles

Walter M. Stadler
Peter H. O'Donnell
Randy Sweis
Theodore Karrison
Aytekin Oto
Milica Medved
Gregory Karczmar
Russell Z. Szmulewitz